Spinal Fusion Stimulator Market

Spinal Fusion Stimulator Market Outlook (2024 to 2034)

The global spinal fusion stimulator was valued at US$ 590.0 million in 2023 and has been forecasted to expand at a noteworthy CAGR of 6.3% to end up at US$ 1,155.4 million by 2034.

A spinal fusion stimulator is a medical device that is used in surgical procedures where two vertebrae are fused or fixed together to avoid friction and movement between the two vertebrae. These stimulators have been shown to have benefits for healing purposes and bone growth.

There are two types of stimulators i.e. external and internal type where internal fusion stimulators are fixed/ implanted at the surgical site and external stimulators use electromagnetic fields to boost bone growth, these external stimulators are worn outside the body.

These devices are used in long-standing diseases such as osteoporosis, trauma, and many others. The rise in arachnoiditis, heart pain (angina) untreatable by other means, spinal cord injuries, amputation., etc. demand the need for spinal fusion stimulators. These devices consist of electrodes and a generator which transmits electrical impulses for improving quality of life.

According to the International Association for the Study of Pain (IASP) 2023, the most common public health problem is chronic pain which hold around 20% of adults reported so far. High-impact chronic pain (HICP) has been shown to impact social, daily life activities and work. HICP people report higher levels of pain affecting various parts of the body thus, impacting mental and physical well-being.

The National Health Interview Survey (NHIS) estimates that 6% to 8% of the individual population suffers from HICP. These statistics have made startups and leading existing players focus on product development which will enhance the demand for stimulators in the coming years.

Report Attributes	Details
Spinal Fusion Stimulator Market Size (2023A)	US$ 590.0 Million
Estimated Market Value (2024E)	US$ 627.2 Million
Forecasted Market Value (2034F)	US$ 1,155.4 Million
Global Market Growth Rate (2024-2034)	6.3% CAGR
East Asia Market Share (2024)	13.4%
China Market Growth Rate (2024-2034)	4.9% CAGR
Key Companies Profiled	Boston Scientific Corporation; Abbott Laboratories; Cirtec Medical; NeuroSigma, Inc.; Synapse Biomedical, Inc.; Greatbatch, Inc.; Beijing PINS Medical Co., Ltd.; Medtronic; Nevro Corp.; Saluda Medical Pty Limited; Stimwave Technologies, Inc.; Other Prominent Players.

Historic Analysis (2019 to 2023) and Future (2024 to 2034) Pathway Analysis for the spinal fusion stimulator market

In 2020, the ageing population estimated by the United Nations (UN) was around 727 Mn individuals which showed a moderate growth in the market. Spinal cord disorders and bone-related clinical conditions are the most commonly seen in the aging population which was the significant market driver. The COVID-19 pandemic hampered the market growth as the elective surgical procedure count saw a downfall. This being for a while, post-pandemic the procedural count went up with a CAGR of 5.6% as per Fact.MR analysis, investment in research and development, and technological advances showed significant growth for the stimulators.

• Short Term (2024 to 2028): The market will witness wealthy growth, growing at a CAGR of 6.3% as per Fact.MR analysis. According to the World Health Organization (WHO) 2024, spinal cord injuries are more prevalent seen in male population than females. These spinal cord injuries have proven to cause neurological disorders and or impairment. Demographically speaking, the adult population suffering from spinal cord injuries has a tough time dealing with unemployment, with rates being more than 60%. These factors will show a positive impact on the market demanding devices that are shown to improve the quality of life of each individual in the short-term period.
• Medium Term (2028 to 2030): The market growth will be stabilized in developed regions, and will enter the phase of maturation. The market expansion in emerging geographies such as Latin America, Asia-Pacific, and Middle East & Africa. Companies are focusing on product development and seeking innovative strategies to serve the underdevelopment market locally and internationally to hold a significant share of the market. The integration of machine learning and AI technologies in practices will certainly drive the demand for Market growth from 2028-2030.
• Long Term (2030 to 2034): As the market enters the phase of maturation in the medium term, there will be intense competition among the leading players. This will further spur product development and enhance personalized treatment suitable to each individual going under surgery. This shift towards personalized treatment is expected to propel the market growth in the long term.

On the back of the aforementioned facts, the spinal fusion stimulator market is anticipated to grow at a CAGR of 6.3% during the forecast period from 2024-2034, According to the Fact.MR, a market research and competitive intelligence provider.

Market Dynamics

What are the Factors Propelling Global Sales of Spinal Fusion Stimulators?

“The Government Support Ecosystem Propels Market Growth Northwards”

There is interest in government in promoting healthy behaviors and healthy communities, managing the spread of diseases, and healthcare infrastructure has benefited individuals across the globe. Similarly, the government also has strategies for managing and overcoming the burden of orthopedic disorders. These Initiatives carried out by the world leaders like the UN, WHO, and SPINE20 have been raising awareness in improving patient’s quality of life.

SPINE20 is a public association, which focuses on treatment action plans, disease management, and creating awareness about spinal disability. This association was established in collaboration with the German Spine Society (GPS), North American Spine Society (NASS), EUROSPINE, and the Saudi Spine Society. Musculoskeletal diseases are the most common causes of disability worldwide.

WHO estimates around 15 million people will be suffering from spinal cord injuries in 2024, which demands spinal cord fusion devices to avoid interruptions in day-to-day activities. SPINE20 in 2019 put forth recommendations for accessing better healthcare services, raising awareness, delivering affordable treatment plans by healthcare workers, and reducing spine-associated disability among the G20 Nations.

This recommendation aligns with Sustainable Development Goals (SDGs) which was proposed by the United Nations in the 2023 summit. These strategies in alleviating the global burden of the disease will propel the market growth in the 2024-2034 forecast years.

“Musculoskeletal Disorders to Impact Global Surgical Volume”

Non-communicable diseases (NCDs) are long-standing disorders that affect all demography, in all age groups but most commonly in an aging population. The NCDs affect millions of people, approximately 41 million people die of NCDs. Musculoskeletal disorders affecting bones and joints have harmed the individual's daily lifestyle.

These statistics encourage manufacturers to develop products and services based on each characteristic. The rise in surgical outpatient count will further increase surgical volumes. Patients undergoing surgical treatments for spinal cord injury and joint disorders will eventually mark the rise in surgery procedures. Thus, a rise in surgical volume will demand stimulator devices propelling the market growth.

What are the Challenges Encountered in the Spinal Fusion Stimulator Market?

“High Cost of Surgical Procedure and Inadequate Reimbursement Policies to Hamper Market Growth”

The cost of devices and procedures varies in different regions. The cost of the products & services is affordable mostly by the high-income demography which is left out on the low-income people. The cost varies between USD 18,000 – and USD 50,000, and the adoption rate of the devices acts as a barrier to the market. Limited reimbursement benefits constraints the market growth.

Not all elective procedures are covered under the insurance plan, which makes the individual face out-of-pocket costs. The coverage is widely utilized in the U.S. and Europe due to a great healthcare infrastructure and the population living in these regions is focused more on self-care. There is immense awareness regarding the benefits of undergoing surgical treatments. The inconsistency of reimbursement coverage makes it less accessible in the low-income group hampering the market growth.

Country-wise Insights

Why is the Adoption of Spinal Fusion Stimulator High in the United States?

“High Prevalence of Spinal Cord Injuries to Propel Market in the U.S.”

The market in the United States is estimated at US$ 223.8 million in 2024 and is projected to expand at a CAGR of 5.7% through 2034.

According to the United Spinal Association, 302,000 individuals in the U.S. suffer from spinal cord injury. The most common cause of spinal cord injury in the U.S. is vehicle accidents holding approximately 39% among the causative factors. The procedure is usually performed more in men than females. To get back to daily activities and lifestyle people seek immediate treatment options propelling the market in the U.S.

Why is China a Lucrative Market for Spinal Fusion Stimulators?

China holds a 68.7% market share in the East Asia Market. This is because of the rising population in China and healthcare awareness programs creating lucrative opportunities for the market to grow in the coming years. The rise in technological advancements, walking with the world, setting up standards, and increase in per capita spending will further boost demand for the stimulators in the country.

Category-wise Insights

Implantable Bone Growth Stimulators are Widely Preferred for the Management of Spinal Cord Injuries?

“Early Recovery and Reduced Hospital Stay to Demand Implantable Bone Growth Stimulators”

Demand for implantable bone growth stimulators is projected to increase at a CAGR of 6.5% from 2024 to 2034. This growth is witnessed by the advantages of using implantable bone growth stimulators, which enhance bone healing and post-surgery recovery. As these devices possess long-term reliability, the adoption rate will bolster the segmental growth in the forecast period.

Why Does the Open Surgery Segment Dominate the Global Spinal Cord Injuries Market?

Open surgeries have been widely adopted for a few decades in treating and managing spinal cord injuries. Open surgeries have been a choice option in treating spinal cord deformities in the aging population. The open surgery segment dominates the market with a 54.5% share in 2024.

What factors will drive the Growth of Hospital Segment in the Forecast Period?

The hospital segment by end user is dominating the market, growing at a CAGR of 4.6% in the forecast period. The availability and easy accessibility of technologically advanced types of equipment and implantable devices will boost the market segment. The availability of skilled surgeons and well-equipped operating rooms will demand spinal fusion devices boosting the market growth. The hospital segment holds a 62.1% market share in the global market.

Competitive Landscape

Key players in the spinal fusion stimulator market are Xstim, Orthofix, Boston Scientific Corporation, Abbott Laboratories, Cirtec Medical, NeuroSigma, Inc., Synapse Biomedical, Inc., Greatbatch, Inc., Beijing PINS Medical Co., Ltd., Medtronic, Nevro Corp., Saluda Medical Pty Limited, and Stimwave Technologies, Inc.

Companies devote a significant portion of their revenue to R&D to resolve problems and offer creative solutions to draw in new customers and stay competitive. Companies are developing customized offerings for issues that meet industry-specific needs to compete with other players.

• In April 2024, Xstim received FDA premarket approval for their spine fusion stimulator device.
• On January 2024, 3Spine completed clinical trial enrollment by pulling off 325 surgeries in 2023.

Fact.MR has provided detailed information about the price points of key manufacturers of spinal fusion stimulators positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of Spinal Fusion Stimulator Industry Research

• By Product Type :

  • Implantable Bone Growth Stimulators
    • Lumbar Fusion Stimulators
    • Cervical Fusion Stimulators
  • External Bone Growth Stimulators
    • Combined Magnetic Field (CMF) Devices
    • Capacitive Coupling (CC) Devices
    • Pulsed Electromagnetic Field (PEMF) Devices

• By Application :

  • Cervical Fusion
  • Thoracic Fusion
  • Lumbar Fusion
  • Others (e.g., Sacral Fusion)

• By Surgery Type :

  • Open Spine Surgery
  • Minimally Invasive Spine Surgery

• By End User :

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Orthopedic Clinics

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa